Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) shares, rose in value on Thursday, January 23, with the stock price down by -2.58% to the previous day’s close as strong demand from buyers drove the stock to $1.89.
Actively observing the price movement in the last trading, the stock closed the session at $1.94, falling within a range of $1.86 and $2.01. The value of beta (5-year monthly) was -0.055. Referring to stock’s 52-week performance, its high was $4.83, and the low was $0.60. On the whole, RVPH has fluctuated by 26.00% over the past month.
With the market capitalization of Reviva Pharmaceuticals Holdings Inc currently standing at about $88.03 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RVPH’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of RVPH currently trading nearly 2.13% and 15.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.71, while the 7-day volatility ratio is showing 10.21% which for the 30-day chart, stands at 15.22%. Furthermore, Reviva Pharmaceuticals Holdings Inc (RVPH)’s beta value is -0.12, and its average true range (ATR) is 0.28.
A comparison of Reviva Pharmaceuticals Holdings Inc (RVPH) with its peers suggests the former has fared considerably weaker in the market. RVPH showed an intraday change of -2.58% in last session, and over the past year, it shrunk by -51.54%%.
Data on historical trading for Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) indicates that the trading volumes over the past 10 days have averaged 3.05 and over the past 3 months, they’ve averaged 2.73 million. According to company’s latest data on outstanding shares, there are 46.58 million shares outstanding.
Nearly 10.62% of Reviva Pharmaceuticals Holdings Inc’s shares belong to company insiders and institutional investors own 29.08% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.3 million shares as on 2024-10-31, resulting in a short ratio of 19.04. According to the data, the short interest in Reviva Pharmaceuticals Holdings Inc (RVPH) stood at 1859.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 5.47 million. The stock has risen by 4.42% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RVPH stock heading into the next quarter.
